.

Pharmaceutical Business Intelligence

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

ACEON Drug Profile

« Back to Dashboard

Which patents cover Aceon, and what substitute generic drugs are available?

Aceon is a drug marketed by Symplmed Pharms Llc and is included in one NDA.

The generic ingredient in ACEON is perindopril erbumine. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the perindopril erbumine profile page.

Summary for Tradename: ACEON

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list66
Clinical Trials: see list2
Patent Applications: see list4,236
Drug Prices:see details
DailyMed Link:ACEON at DailyMed

Pharmacology for Tradename: ACEON

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-001Dec 30, 1993RXYesNo► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-002Dec 30, 1993RXYesNo► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-003Dec 30, 1993RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ACEON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-001Dec 30, 19934,508,729► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-003Dec 30, 19935,162,362► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-001Dec 30, 19935,162,362► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-003Dec 30, 19934,508,729► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-002Dec 30, 19935,162,362► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ACEON

Drugname Dosage Strength RLD Submissiondate
perindopril erbumineTablets2 mg, 4 mg and 8 mgAceon6/6/2006
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc